Moty Klepfish PhD., Vice President of Therapeutic Areas

Dr. Moty Klepfish brings over 8 years of experience in drug development across multiple therapeutic areas, including oncology, fibrosis, and neuroscience. With a strong foundation in immunology, imaging, and in vivo models, he has led several programs from early discovery to IND-enabling studies.

Before joining Anima Biotech, he worked at Compugen, where he developed antibodies targeting myeloid immune checkpoints in the field of immuno-oncology. Since joining Anima seven years ago, he has held various roles, including Project Manager and heading the Therapeutic Areas group, where he has overseen cross-functional drug discovery programs across the company's pipeline.